Composition
- Active ingredients
- DICLOXACILLIN SODIUM EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DICLOXACILLIN SODIUM EQ 62.5MG BASE/5ML · For suspensionNDA050092-001 · Discontinued
- DICLOXACILLIN SODIUM EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleThis page
- DICLOXACILLIN SODIUM EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA050011-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050011.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Pathocil
- Active substance
- dicloxacillin sodium
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Wyeth Ayerst
- Status
- Discontinued
- FDA approval
- 9 May 1968
- Application
- NDA050011-003